Case Reports
doi: 10.1002/ccr3.895.
eCollection 2017 May.
Providing full recovery with single-dose intravenous reteplase in a patient presented to emergency department with acute ischemic stroke
Affiliations
- PMID: 28469857
- PMCID: PMC5412899
- DOI: 10.1002/ccr3.895
Item in Clipboard
Case Reports
Providing full recovery with single-dose intravenous reteplase in a patient presented to emergency department with acute ischemic stroke
Clin Case Rep.
.
Abstract
Administration of intravenous reteplase might be a choice of treatment of acute ischemic stroke.
Keywords: Acute ischemic stroke; intravenous; reteplase; treatment.
Similar articles
-
Safety and Efficacy of Reteplase Versus Alteplase for Acute Ischemic Stroke: A Phase 2 Randomized Controlled Trial.Stroke. 2024 Feb;55(2):366-375. doi: 10.1161/STROKEAHA.123.045193. Epub 2023 Dec 28. Stroke. 2024. PMID: 38152962 Clinical Trial.
-
Intraarterial reteplase and intravenous abciximab for treatment of acute ischemic stroke. A preliminary feasibility and safety study in a non-human primate model.Neuroradiology. 2005 Nov;47(11):845-54. doi: 10.1007/s00234-003-1097-7. Epub 2005 Oct 5. Neuroradiology. 2005. PMID: 16205896
-
Making a case for the right '-ase' in acute ischemic stroke: alteplase, tenecteplase, and reteplase.Expert Opin Drug Saf. 2019 Feb;18(2):87-96. doi: 10.1080/14740338.2019.1573985. Expert Opin Drug Saf. 2019. PMID: 30712409 Review.
-
Feasibility and timing of prehospital administration of reteplase in patients with acute myocardial infarction.J Thromb Thrombolysis. 2002 Jun;13(3):147-53. doi: 10.1023/a:1020474822885. J Thromb Thrombolysis. 2002. PMID: 12355031 Clinical Trial.
-
Reteplase: a review of its use in the management of thrombotic occlusive disorders.Am J Cardiovasc Drugs. 2006;6(4):265-85. doi: 10.2165/00129784-200606040-00007. Am J Cardiovasc Drugs. 2006. PMID: 16913828 Review.
Cited by
-
MGATRx: Discovering Drug Repositioning Candidates Using Multi-View Graph Attention.IEEE/ACM Trans Comput Biol Bioinform. 2022 Sep-Oct;19(5):2596-2604. doi: 10.1109/TCBB.2021.3082466. Epub 2022 Oct 10. IEEE/ACM Trans Comput Biol Bioinform. 2022. PMID: 34014830 Free PMC article.
-
A Molecular Troika of Angiogenesis, Coagulopathy and Endothelial Dysfunction in the Pathology of Avascular Necrosis of Femoral Head: A Comprehensive Review.Cells. 2023 Sep 14;12(18):2278. doi: 10.3390/cells12182278. Cells. 2023. PMID: 37759498 Free PMC article. Review.
-
Dual role of vascular endothelial growth factor-C in post-stroke recovery.J Exp Med. 2025 Feb 3;222(2):e20231816. doi: 10.1084/jem.20231816. Epub 2024 Dec 12. J Exp Med. 2025. PMID: 39665829 Free PMC article.
References
-
- Jauch, E. C. , Saver J. L., Adams H. P. Jr, Bruno A., Connors J. J., Demaerschalk B. M., et al. 2013. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 44:870–947. - PubMed
-
- Ali, R. , Hossain M. S., Islam A., Arman S. I., Raju G. S., Dasgupta P., et al. 2014. Aspect of thrombolytic therapy: a review. ScientificWorldJournal 2014:8. doi:10.1155/2014/586510. - DOI - PubMed
-
- U.S. Food and Drug Administration . Reteplase Product Approval Information ‐ Licensing Action . U.S. Department of Health and Human Services [Online] June 15, 2016. Available at: http://www.fda.gov/drugs/developmentapprovalprocess/howdrugsaredeveloped... (accessed November 29, 2016).
-
- Yenari, M. A. , Lee L. K., Beaulieu C., et al. 1998. Thrombolysis with reteplase, an unglycosylated plasminogen activator variant, in experimental embolic stroke. J. Stroke Cerebrovasc. Dis. 7:179–186. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
